ArticleFoods (Basel, Switzerland)2025
Evaluation of Buriti (
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Recent studies have focused on the development of food packaging films based on biopolymers, with polysaccharides being at the forefront due to their abundant availability in food and agricultural by-products. Therefore, it was the aim of this work to prepare and characterize conjugated biopolymeric films using starch, galactomannans and buriti oil (BO), with the latter acting as a partial or integral replacement for glycerol as a plasticizer. The addition of BO to either the starch or the conjugated starch-galactomannan film formulations led to distinct interactions between the components and consequently to films with distinct properties. The addition of both BO and galactomannan to starch hindered retrogradation, characterized by a diminished degree of crystallinity in comparison to the film containing only starch, attesting the stabilization of the starch molecular structures in its interaction with galactomannan molecules and with the emulsified BO. The analyses of films' mechanical properties demonstrated that the added BO did not act as a plasticizer, leading to increased tensile strength and elastic modulus and decreased elongation at break in all formulations. Overall, the films containing starch presented lower mechanical resistance than the ones based on galactomannan. All formulations led to biodegradable films, with those with BO taking longer to degrade.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.